Phase I randomized, placebo-controlled, cross-over dose-finding pharmacokinetic study of Coenzyme Q10 during one cycle of doxorubicin treatment for breast cancer
Heather Greenlee, ND, PhD, MPH1,2,3, Katherine D. Crew, MD, MS1,2,4, Mathew Maurer, MD2,4, Kevin Kalinsky, MD2,4, Serge Cremers, PharmD, PhD5,6, Ali Naini, PhD6,7, Wei Yann Tsai, PhD1,2, Zaixing Shi, PhD1,6, Frances Brogan2, Dawn L. Hershman, MD, MS1,2,4
1 Mailman School of Public Health, Columbia University, New York, NY
2 Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
3 Fred Hutchinson Cancer Research Center, Seattle, WA
4 Vagelos College of Physicians and Surgeons, Columbia University, New York, NY
5 Irving Institute for Clinical and Translational Research, Columbia University, New York, NY
6 Department of Pathology and Cell Biology, Columbia University, New York, NY
7 Department of Neurology, Columbia University, New York, NY